As of April 16, 2025, Natera (NTRA) has a market cap of $20.51 billion USD. According to our data, Natera is ranked No.907 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $20.51 B |
-1.85%
|
Dec 31, 2024 | $20.90 B |
152.71%
|
Dec 29, 2023 | $8.27 B |
55.94%
|
Dec 30, 2022 | $5.30 B |
-56.99%
|
Dec 31, 2021 | $12.33 B |
-6.16%
|
Dec 31, 2020 | $13.14 B |
195.40%
|
Dec 31, 2019 | $4.45 B |
141.33%
|
Dec 31, 2018 | $1.84 B |
55.28%
|
Dec 29, 2017 | $1.19 B |
-23.23%
|
Dec 30, 2016 | $1.55 B |
8.43%
|
Dec 31, 2015 | $1.43 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Guardant Health
GH
|
$5.54 B |
0.000 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$8.11 B |
-0.000 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.74 B |
-0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.22 B |
0.000 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.59 B |
0.000 M
|
![]() USA
|
![]() Personalis
PSNL
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.15 B |
0.000 M
|
![]() USA
|
![]() Pacific Biosciences
PACB
|
$0.38 B |
-0.000 M
|
![]() USA
|
![]() 10x Genomics
TXG
|
$1.00 B |
0.115 B
|
![]() USA
|
![]() Twist Bioscience
TWST
|
$2.36 B |
-0.000 M
|
![]() USA
|
![]() Veracyte
VCYT
|
$2.48 B |
0.000 M
|
![]() USA
|
Market Cap | = | NTRA Stock Price | * | NTRA Shares Outstanding |
= | $151.74 | * | 0.14 B | |
= | $20.51 B |